UK Digital Pathology Market Size & Outlook, 2023-2030
UK digital pathology market, 2018-2030 (US$M)
Related Markets
UK digital pathology market highlights
- The UK digital pathology market generated a revenue of USD 48.4 million in 2023 and is expected to reach USD 85.9 million by 2030.
- The UK market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
| Market revenue in 2023 | USD 48.4 million |
| Market revenue in 2030 | USD 85.9 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, UK accounted for 4.7% of the global digital pathology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany digital pathology market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 85.9 million by 2030.
Device was the largest segment with a revenue share of 52.27% in 2023. Horizon Databook has segmented the UK digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
The UK digital pathology market is expected to witness remunerative growth opportunities over the coming years. The growth can be attributed to growing preference for digital pathology as a result of associated benefits. These benefits include easier access to slides, reduced risk of errors and rapid diagnosis. Growing number of cancer cases in the UK is also high impact rendering growth driver for digital pathology in the UK.
According to Cancer Research UK, cancer incidence was found to be approximately 363,484 cases in the UK every year, which mostly affects the population aged 85-89 years and above. More than half of the new cases were of prostate, breast, bowel, or lung cancer. As a result of growing significance of digital pathology in cancer diagnosis, in 2016, the Cancer Research UK recommended to invest in technology upgradation to support digital pathology.
Initiatives undertaken by organizations such as the National Pathology Programme by the NHS England that aims for innovation and digitization in pathology. Such initiatives are undertaken to prevent premature mortality through early diagnosis as well as support clinical teams to interpret test results for patient efficiently.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK digital pathology market size, by product, 2018-2030 (US$M)
UK Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
